Don't panic sell tomorrow .... the current price might already price in the bad qr result. u guys can take lctitan ... misc and mflour and saprng as reference. their share price gone higher after very bad qr report

the chart is not conclusive of anything. obvious facts is that they r running their plant at 95% of utilization . and their in hand order already till end of this year and some other company already till next year. us is not their only buyer

Tell me that which stock u buy is 100% chance? I guess u wont be if u can buy stock 100% chance. Investment is always with risk. But, u know the fundamental , then u invest with the calculated risk.

Its not bet ... its from fundamental.

Harta and topglove both are component of KLCI index stock. Which stock in KLCI index will local institutional buy in if they want to support or push the index higher? since all the klci index stock are not doing well during covid pandemic.

Bear in mind that harta share holders are mostly institutional investors ... Its way safer than investing those small cap company. And now harta and topglove are the best place for those fund to park to hedge against depreciation of currency. There are no other sectors doing well during these covid pandemic eventhough banking sector. Imagine what will happen if those smart money flowing in .... hit RM 12 is just matter of time. Retailers always lose because they cannnot overcome their fear.

https://koonyewyin.com/2020/05/17/comfort-compares-with-supermax/

Supermx will rocket up to RM 5.00 soon .... momentum is strong. Ride the bull with the sharks .... Don't be shaken out by the shark to collect your ticket cheap.

Just hold tide your ticket and don't be shaken out by shark to collect your ticket cheap. When the music is ongoing,no point we leave the party now.

Harta and topglove will keep going as covid pandemic is still ongoing and it might continue for years as long as the vaccine is not out yet. Harta will benefit from that and the current PE is accepted with calculated projection. Riverstone which is the player from the same field of manufacturing nitrile glove had reported their JAN - MARCH result with 40-50% growth. Covid fullblown outbreak is during March - May. Therefore, Result for all the glove manufacturers will have even more superb result for their subsequent quater. Retailers always lose in the market because retailers always afraid to buy high PE stock and ride the bull with the shark. High PE stock are the one which will grow higher and higher just like Amazon.

Us gonna issue another huge amount of QE to save their economy. Currency gonna depreciate more and more due to inflation. Holding cash is not a good idea for now. If u r fund manager, who is holding alot fund of investors. What r u going to do when currency is depreciating? Hold cash? or parking their fund at some counters with potential growth which can hedge the inflation? So, with the current economy and market sentiment. Which counters do u think is the best for them to park their fund at?They won't park their fund at penny stock or stock from ace market. So, Topglove and harta will be their best choice? Just bullish like FAANG stock of US market ...... Think about that ....

Next tuesday will be crude oil future contract due date, better becareful for another huge drop to negative again. Best timing to enter oil ane gas counter is after tuesday ... not now.

Harta might worth RM 12 by end of year of 2020 ... provided covid outbreak still ongoing

These analyst report will u guys to have some idea on harta coming QR. I expect minimum 30% QoQ increment in profit with EPS of 4.65. 4 x 4.65 = 18.6 sen. With Normal PE for harta of 50, 50 x 0.186 = RM 9.30. This is the price Harta is worth for now and this haven't factor in monthly increment of average selling price which started in march- may 2020. And this average selling price will be increasing at 5-10% per month. Calculate yourself the further upside of harta ....

Good catalyst for better margin :
1) RM depreciation which is good for export
2) Lower cost price for nitrile glove ( Butadiene)
3) Monthly increasing average selling price （ 5 to 10% per month )

https://research.sginvestors.io/2020/05/top-glove-maybank-kim-eng-research-2020-05-12.html?m=1

https://research.sginvestors.io/2020/05/riverstone-holdings-uob-kay-hian-research-2020-05-07.html?m=1

https://research.sginvestors.io/2020/05/riverstone-holdings-dbs-group-research-2020-05-12.html?m=1

lets buy riverstone .... still big room to up

lets buy riverstone .... still big room to up

Erm .... i still think riverstone is still undervalued if compare to supermax and comfort

PE 25
Gross margin 20.11%
Net profit margin 13.19%

and company keep growing for the past few years. And their new production line will start in dec 2020 and will increase their total production by 10-15%. They covering the market in us , china , philipine, malaysia and thailand.

Riverstone is way undervalued ..... sgx glove counter. Lower PE, Higher gross margin and profit margin, nitrile glove manufacturer and low debt. Malaysia glove counters already overpriced

Time to swith to riverstone ..... sgx glove counter. Lower PE, Higher gross margin and profit margin, nitrile glove manufacturer and low debt. Still very undervalued

https://www.youtube.com/watch?v=SK27HuFkdWs

https://www.thestar.com.my/business/business-news/2020/01/29/quick-take-pos-malaysia-shares-up-6-on-postage-rates-revision

https://kenanga.com.my/wp-content/uploads/2020/02/POS-200129-CU.pdf

some branches their parcel number increased 300% as compared to before mco lockdown.

Courrier service company will be one of the sector benefit the most from covid during and even after pandemic. TP 1.95

Good news for longer period of goreng .... lets goreng

Tomorrow maybe will be another profit taking day ..... beware. Market sentiment is not good

My group and me just sold off our stake at 0.84 - 0.865 for profit taking. We will re-enter again at price below 0.825. MCO is good for pos malaysia. my group and me just talk to pos malaysia people. They said their parcels from ecommerce increases tremendously during MCO due to people cannot go out to buy stuff and they buy daily needs through online eccomerce platform. According to pos malaysia people, another reason that their daily parcels increased during MCO because some of their competitors closed down during MCO.
I think POS malaysia is going to make a come back this year as covid 19 lockdown will make public more more expose to eccomerce shopping and thus fasten the growth of ecommerce sector and courrier service sector.

supermx is in correction now ..... it made lower high this morning.... it din mange to breakout yesterday high and break yesterday supp level .... it has turned to downtrend correction now. supp level at 2.26 ... 2.17 .... 2.06. Good luck

Selling volume is huge from the intraday chart today .... and din manage to breakout from yesterday high 1.37 this morning , now forming bearish engulfing signal .... comfort will go into consolidation .... first level to test at 1.25, if break then 1.17 .....

Better leave and observation first ...

Tomorrow will be another sbb. Stay tune. Dont miss the boat to TP RM 3

Most of the glove counters up 50 -150% during disease outbreak accoarding to history . for example during sars/ebola/mers outbreak

Their glove order in hand already fulled untill july - september 2020.

supermax will go rm 3.00 .....tmr gap up

hahaahha ......... when he said can cross RM 2 mean u start selling. Don't u get the hint?

hahaha ..... he wrote the article yesterday after topglove and harta turned red after long bulliish run. Wonder he started releasing his stake now

The stock market is never obvious. It is designed to fool most of the people, most of the time- Jesse Livermore

Do u think aliance bank can stay green if maybank, public bank and cimb bank stay red? haha

The leading counters of glove sector, harta , top glove and kossan are all in red for 2 days. Its amazing that comfort can solely stay green. Leave before big shark release their stake to u

The profit is not sustainable ... demand will drop and back to normal after covid. All the glove counters already overvalued as they have priced in the profit from covid pandemic which will be announced in 2 months alter

Comfort PE all the while only worth PE 15-18 due to their product margin ... its about 7%
Supermax with higher margin of 9% only worth PE 25

Glove counters rally will end soon ............ Covid number of cases already peak and on downtrend , and soon will be under controlled. Topglove and harta starting to drop from its peak. 2nd and 3rd line glove counter will follow the trend soon .Demand of glove will drop drastically afterthat. Its time to leave and collect handsome profit.

krono will continue to go higher !!!! But, it wont be in straight line .... bear my words

2020/04/04 中時電子報 馮英志

重大突破！澳發現新冠剋星 48小時內殺死病毒RNA

澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）
澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）

對抗新冠病毒藥物相關研究有重大突破！據澳洲聯合新聞社報導，蒙納許大學（Monash University）研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒核糖核酸（RNA）。雖然此一藥物已普遍使用，但最快1個月才會進入人體實驗階段。該結論已發表在《抗病毒研究》（Antiviral Research）雜誌上。


報導指出，蒙納許大學生物成像研究所的瓦格斯塔夫（Kylie Wagstaff）博士3日指出，使用單劑量的抗頭蝨的藥物「伊維菌素」，可以在48小時內阻止新冠病毒在細胞培養中生長。

瓦格斯塔夫指出，單劑量的伊維菌素注射，本也能在48小時內清除病毒所有的核糖核酸（RNA），在24小時內能夠顯著減少其RNA。

報導指出，目前仍不清楚伊維菌素是如何殺死新冠病毒，但該藥物很明顯阻止了病毒的抑制能力，讓此病毒無法抑制宿主細胞對其進行清理。科學家們下一階段將確定合適人體使用的劑量，以確保實驗室外的劑量對人體安全。

瓦格斯塔夫表示，在全球新冠疫情仍在大流行、且當前仍未有治療藥物及正式獲准生產的方案情況下，這種現成的合成藥若證實有效，可能提早對患者有幫助。此外他也強調，要廣泛使用疫苗仍需一段時間，該團隊也需要資金進行臨床實驗與測試。

2020/04/04 中時電子報 馮英志

重大突破！澳發現新冠剋星 48小時內殺死病毒RNA

澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）
澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）

對抗新冠病毒藥物相關研究有重大突破！據澳洲聯合新聞社報導，蒙納許大學（Monash University）研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒核糖核酸（RNA）。雖然此一藥物已普遍使用，但最快1個月才會進入人體實驗階段。該結論已發表在《抗病毒研究》（Antiviral Research）雜誌上。


報導指出，蒙納許大學生物成像研究所的瓦格斯塔夫（Kylie Wagstaff）博士3日指出，使用單劑量的抗頭蝨的藥物「伊維菌素」，可以在48小時內阻止新冠病毒在細胞培養中生長。

瓦格斯塔夫指出，單劑量的伊維菌素注射，本也能在48小時內清除病毒所有的核糖核酸（RNA），在24小時內能夠顯著減少其RNA。

報導指出，目前仍不清楚伊維菌素是如何殺死新冠病毒，但該藥物很明顯阻止了病毒的抑制能力，讓此病毒無法抑制宿主細胞對其進行清理。科學家們下一階段將確定合適人體使用的劑量，以確保實驗室外的劑量對人體安全。

瓦格斯塔夫表示，在全球新冠疫情仍在大流行、且當前仍未有治療藥物及正式獲准生產的方案情況下，這種現成的合成藥若證實有效，可能提早對患者有幫助。此外他也強調，要廣泛使用疫苗仍需一段時間，該團隊也需要資金進行臨床實驗與測試。

2020/04/04 中時電子報 馮英志

重大突破！澳發現新冠剋星 48小時內殺死病毒RNA

澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）
澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）

對抗新冠病毒藥物相關研究有重大突破！據澳洲聯合新聞社報導，蒙納許大學（Monash University）研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒核糖核酸（RNA）。雖然此一藥物已普遍使用，但最快1個月才會進入人體實驗階段。該結論已發表在《抗病毒研究》（Antiviral Research）雜誌上。


報導指出，蒙納許大學生物成像研究所的瓦格斯塔夫（Kylie Wagstaff）博士3日指出，使用單劑量的抗頭蝨的藥物「伊維菌素」，可以在48小時內阻止新冠病毒在細胞培養中生長。

瓦格斯塔夫指出，單劑量的伊維菌素注射，本也能在48小時內清除病毒所有的核糖核酸（RNA），在24小時內能夠顯著減少其RNA。

報導指出，目前仍不清楚伊維菌素是如何殺死新冠病毒，但該藥物很明顯阻止了病毒的抑制能力，讓此病毒無法抑制宿主細胞對其進行清理。科學家們下一階段將確定合適人體使用的劑量，以確保實驗室外的劑量對人體安全。

瓦格斯塔夫表示，在全球新冠疫情仍在大流行、且當前仍未有治療藥物及正式獲准生產的方案情況下，這種現成的合成藥若證實有效，可能提早對患者有幫助。此外他也強調，要廣泛使用疫苗仍需一段時間，該團隊也需要資金進行臨床實驗與測試。

2020/04/04 中時電子報 馮英志

重大突破！澳發現新冠剋星 48小時內殺死病毒RNA

澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）
澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）

對抗新冠病毒藥物相關研究有重大突破！據澳洲聯合新聞社報導，蒙納許大學（Monash University）研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒核糖核酸（RNA）。雖然此一藥物已普遍使用，但最快1個月才會進入人體實驗階段。該結論已發表在《抗病毒研究》（Antiviral Research）雜誌上。


報導指出，蒙納許大學生物成像研究所的瓦格斯塔夫（Kylie Wagstaff）博士3日指出，使用單劑量的抗頭蝨的藥物「伊維菌素」，可以在48小時內阻止新冠病毒在細胞培養中生長。

瓦格斯塔夫指出，單劑量的伊維菌素注射，本也能在48小時內清除病毒所有的核糖核酸（RNA），在24小時內能夠顯著減少其RNA。

報導指出，目前仍不清楚伊維菌素是如何殺死新冠病毒，但該藥物很明顯阻止了病毒的抑制能力，讓此病毒無法抑制宿主細胞對其進行清理。科學家們下一階段將確定合適人體使用的劑量，以確保實驗室外的劑量對人體安全。

瓦格斯塔夫表示，在全球新冠疫情仍在大流行、且當前仍未有治療藥物及正式獲准生產的方案情況下，這種現成的合成藥若證實有效，可能提早對患者有幫助。此外他也強調，要廣泛使用疫苗仍需一段時間，該團隊也需要資金進行臨床實驗與測試。

2020/04/04 中時電子報 馮英志

重大突破！澳發現新冠剋星 48小時內殺死病毒RNA

澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）
澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）

對抗新冠病毒藥物相關研究有重大突破！據澳洲聯合新聞社報導，蒙納許大學（Monash University）研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒核糖核酸（RNA）。雖然此一藥物已普遍使用，但最快1個月才會進入人體實驗階段。該結論已發表在《抗病毒研究》（Antiviral Research）雜誌上。


報導指出，蒙納許大學生物成像研究所的瓦格斯塔夫（Kylie Wagstaff）博士3日指出，使用單劑量的抗頭蝨的藥物「伊維菌素」，可以在48小時內阻止新冠病毒在細胞培養中生長。

瓦格斯塔夫指出，單劑量的伊維菌素注射，本也能在48小時內清除病毒所有的核糖核酸（RNA），在24小時內能夠顯著減少其RNA。

報導指出，目前仍不清楚伊維菌素是如何殺死新冠病毒，但該藥物很明顯阻止了病毒的抑制能力，讓此病毒無法抑制宿主細胞對其進行清理。科學家們下一階段將確定合適人體使用的劑量，以確保實驗室外的劑量對人體安全。

瓦格斯塔夫表示，在全球新冠疫情仍在大流行、且當前仍未有治療藥物及正式獲准生產的方案情況下，這種現成的合成藥若證實有效，可能提早對患者有幫助。此外他也強調，要廣泛使用疫苗仍需一段時間，該團隊也需要資金進行臨床實驗與測試。

2020/04/04 中時電子報 馮英志

重大突破！澳發現新冠剋星 48小時內殺死病毒RNA

澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）
澳洲研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒細胞，該結論已發表在《抗病毒研究》雜誌上。（示意圖／美聯社）

對抗新冠病毒藥物相關研究有重大突破！據澳洲聯合新聞社報導，蒙納許大學（Monash University）研究團隊發現，主要用來治療頭蝨的「伊維菌素」（Ivermectin）可在2日之內殺死新冠病毒核糖核酸（RNA）。雖然此一藥物已普遍使用，但最快1個月才會進入人體實驗階段。該結論已發表在《抗病毒研究》（Antiviral Research）雜誌上。


報導指出，蒙納許大學生物成像研究所的瓦格斯塔夫（Kylie Wagstaff）博士3日指出，使用單劑量的抗頭蝨的藥物「伊維菌素」，可以在48小時內阻止新冠病毒在細胞培養中生長。

瓦格斯塔夫指出，單劑量的伊維菌素注射，本也能在48小時內清除病毒所有的核糖核酸（RNA），在24小時內能夠顯著減少其RNA。

報導指出，目前仍不清楚伊維菌素是如何殺死新冠病毒，但該藥物很明顯阻止了病毒的抑制能力，讓此病毒無法抑制宿主細胞對其進行清理。科學家們下一階段將確定合適人體使用的劑量，以確保實驗室外的劑量對人體安全。

瓦格斯塔夫表示，在全球新冠疫情仍在大流行、且當前仍未有治療藥物及正式獲准生產的方案情況下，這種現成的合成藥若證實有效，可能提早對患者有幫助。此外他也強調，要廣泛使用疫苗仍需一段時間，該團隊也需要資金進行臨床實驗與測試。

https://www.msn.com/zh-tw/news/world/%E5%A5%BD%E6%B6%88%E6%81%AF%EF%BC%8148%E5%B0%8F%E6%99%82%E5%85%A7%E6%AE%BA%E5%85%89%E7%B4%B0%E8%83%9E-%E6%BE%B3%E6%B4%B2%E5%9C%98%E9%9A%8A%E7%99%BC%E7%8F%BE%E6%AD%A6%E8%82%BA%E7%97%85%E6%AF%92%E5%89%8B%E6%98%9F/ar-BB129tn3

https://www.dailymail.co.uk/news/article-8186287/Monash-University-scientists-anti-parasite-Ivermectin-kill-COVID-19-cells-two-days.html